Explore the 2025 Agenda
In June 2025, the in vivo community came together to discover the latest in vivo clinical data, therapeutic updates and explore how to advance the future of in vivo approaches.
Inside You'll Find...
 |
Revolutionary preclinical and IND data across CAR-T, mRNA and gene editing modalities |
|
A dynamic workshop day providing insights into RNP and protein delivery vehicles and the latest strategies for navigating regulatory pathways |
|
Industry led expert discussions, evaluating the future of the in vivo cell and gene space, overcoming treatment toxicity and navigating the path to the clinic |
|
20+ expert speakers from across the in vivo cell engineering and gene editing space, including senior representatives from Capstan Therapeutics, Carisma Therapetuics, Editas Medicine and more! |
Having issues downloading? Click here to request a copy of the agenda!
"This series leads the race on placing in vivo gene medicines, and particularly in vivo CAR therapy, on the map"
Adrian Bot, Chief Scientific Officer, Capstan Therapeutics
